0001209191-18-008272.txt : 20180207
0001209191-18-008272.hdr.sgml : 20180207
20180207200609
ACCESSION NUMBER: 0001209191-18-008272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180205
FILED AS OF DATE: 20180207
DATE AS OF CHANGE: 20180207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pope Todd
CENTRAL INDEX KEY: 0001584367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 18582485
MAIL ADDRESS:
STREET 1: C/O TRANSENTERIX
STREET 2: 635 DAVIS DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-05
0
0000876378
TRANSENTERIX INC.
TRXC
0001584367
Pope Todd
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
1
1
0
0
President and CEO
Common Stock
2018-02-05
4
M
0
126556
0.00
A
356556
D
Common Stock
2018-02-05
4
F
0
40484
1.53
D
316072
D
Stock Option
1.39
2018-02-07
4
A
0
1403000
0.00
A
2028-02-07
Common Stock
1403000
1403000
D
Restricted Stock Units
0.00
2018-02-07
4
A
0
312000
0.00
A
Common Stock
312000
312000
D
Restricted Stock Units
2018-02-05
4
M
0
40556
0.00
D
Common Stock
40556
40555
D
Restricted Stock Units
2018-02-05
4
M
0
33333
0.00
D
Common Stock
33333
0
D
Restricted Stock Units
2018-02-05
4
M
0
52667
0.00
D
Common Stock
52667
105333
D
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan.
Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 104,000 on each of February 4, 2019, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan.
Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan.
/s/ Joshua Weingard,as Attorney-in-Fact for Todd Pope
2018-02-07